[Letter: Oral antidiabetics and cardiovascular disorders].
D002318:Cardiovascular Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008875:Middle Aged; D010629:Phenformin / Q000009:adverse effects; D014044:Tolbutamide / Q000009:adverse effects
D007004:Hypoglycemic Agents; D014044:Tolbutamide; D010629:Phenformin
Per os te gebruiken bloedsuikerverlagende geneesmiddelen en cardiovasculaire aandoeningen